Maligne Melanome der Haut

  • I. Krüger
  • R. Huber

Zusammenfassung

Das maligne Melanom ist ein seltener, von den Melanozyten ausgehender Tumor. Obwohl der Anteil des malignen Melanoms an allen Neoplasien des Menschen lediglich ca. 1 % ausmacht, nimmt seine Inzidenz rascher zu als die der meisten anderen Malignome. Aus der Mehrzahl der epidemiologischen Studien geht hervor, daß sich die Inzidenz der Hautmelanome unter der weißen Bevölkerung in der ganzen Welt alle 6–10 Jahre verdoppelt. Zur Zeit muß mit einer Inzidenz von 10–12 Neuerkrankungen pro 100000 Einwohner gerechnet werden [16].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Balch CM (1980) Surgical management of regional lymph nodes in cutaneous melanoma. J Am Acad Dermatol 3: 511PubMedCrossRefGoogle Scholar
  2. 2.
    Balch CM, Milton OW (1985) Diagnosis of metastatic melanoma at distant sites. In: Balch CM, Milton OW (eds) Cutaneous melanoma clinical management and treatment results worldwide. Lippincott, PhiladelphiaGoogle Scholar
  3. 3.
    Balch CM, Soong SJ, Milton OW et al. (1982) A comparison of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 196: 677PubMedCrossRefGoogle Scholar
  4. 4.
    Balch CM, Cascinelli N, Milton GW, Sim FH (1985) Elective lymph node dissection: pros and cons. In: Balch CM, Milton GW (eds) Cutaneous melanoma clinical management and treatment results worldwide. Lippincott, Philadelphia.Google Scholar
  5. 5.
    Bears OH, Myers MH (1983) Manual for staging of cancer. American Joint Committee for Cancer Staging. Lippincott, PhiladelphiaGoogle Scholar
  6. 6.
    Braun-Falco O (1974) Maligne Melanome der Haut aus dermatologischer Sicht. Chirurg 45: 345PubMedGoogle Scholar
  7. 7.
    Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902PubMedCrossRefGoogle Scholar
  8. 8.
    Breslow A, Macht SD (1977) Optimal size of resection margin for thin cutaneous melanoma. Surg Gynecol Obstet 145: 691PubMedGoogle Scholar
  9. 9.
    Cascinelli N, Preda F, Vaglini M et al. (1983) Metastatic spread of stage I melanoma of the skin. Tumori 69: 449Google Scholar
  10. 10.
    Cascinelli N, Santinami M, Urist MM et al. (1987) Indications for management of primary melanoma. In: Veronesi U, Cascinelli N, Santiami M (eds.) Cutaneous melanoma. Status of know 1- edge and future perspective. Karger, Basel p 545Google Scholar
  11. 11.
    Clark WH, From L, Bernardino EA, Mihm MC (1969) The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29: 705PubMedGoogle Scholar
  12. 12.
    Creech O, Krementz ET, Ryan RF, Winblad NJ (1958) Regional perfusion utilizing an extracorporeal circulation. Ann Surg 148: 616PubMedCrossRefGoogle Scholar
  13. 13.
    Garbe C, Bertz J, Orfanos CE (1987) Das maligne Melanom im deutschsprachigen Raum in den 80iger Jahren. Hautarzt 38: 639PubMedGoogle Scholar
  14. 14.
    Ghussen F, Pichlmaier H (1988) Das maligne Melanom der Haut. Dtsch Ärztebl 85: 1129Google Scholar
  15. 15.
    Hermanek P, Scheibe, O, Spiessl B, Wagner G (Hrsg) (1987) TNM-Klassifikation maligner Tumoren, 4. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  16. 16.
    Hundeicker M (1987) Diagnostische Merkmale der malignen Melanome und zur Melanomentwicklung neigender Pigmentmale. Dtsch Med Wochenschr 112: 551CrossRefGoogle Scholar
  17. 17.
    Ketcham AS, Balch CM (1985) Classifications and staging systems. In: Balch CM, Milton GW (eds) Cutaneous melanoma clinical management and treatment results worldwide. Lippincott, PhiladelphiaGoogle Scholar
  18. 18.
    Koh KH, Sober AJ, Day JR et al. (1986) Prognosis of clinical stage I melanoma patients with positive elective regional node dissection. J Clin Oncol 4: 1238PubMedGoogle Scholar
  19. 19.
    Krementz ET, Ryan RF (1972) Chemotherapy of melanoma of the extremities by perfusion: fourteen years of clinical experience. Ann Surg 175: 900PubMedCrossRefGoogle Scholar
  20. 20.
    Krementz ET, Ryan RF, Carter RD et al. (1985) Hyperthermic perfusion for melanoma of the limbs. In: Balch CM, Milton GW (eds) Cutaneous melanoma clinical management and treatment results worldwide. Lippincott, Philadelphia, p 171Google Scholar
  21. 21.
    McCarthy WH, Shaw HM, Milton GW (1985) Efficacy of elective lymph node dissection in 2347 patients with clinical stage I malignant melanoma. Surg Gynecol Obstet 161: 575PubMedGoogle Scholar
  22. 22.
    McPeak CJ, McNeer GP, Whiteley HW, Booher RJ (1963) Amputation for melanoma of the extremity. Surgery 54: 426PubMedGoogle Scholar
  23. 23.
    Sim FH, Taylor WF, Pritchard DJ, Soule EH (1986) Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 61: 697PubMedGoogle Scholar
  24. 24.
    Stehlin JR (1969) Hyperthermic perfusion with chemotherapy for cancer ofthe extremities. Surg Gynecol Obstet 129: 305PubMedGoogle Scholar
  25. 25.
    Sylven B (1949) Malignant melanoma of the skin. Acta Radiol 32: 33PubMedCrossRefGoogle Scholar
  26. 26.
    Turnbull A, Shah J, Fortner J (1973) Recurrent melanoma of an extremity treated by major amputation. Arch Surg 106: 496PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • I. Krüger
  • R. Huber

There are no affiliations available

Personalised recommendations